Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: A randomized, double-blind, placebo controlled study

Indian Journal of Dermatology, Venereology and Leprology

Volumn 72, Issue 5, 2006, Pages 346-349

  Fariba, Iraji ^a,c   Ali, Asilian ^a   Hossein, Siadat ^b   Atefeh, Safavai ^a   Afshin, Atar Zadeh Behbahan Seyed ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Actinic keratosis; Diclofenac gel; Treatment

Indexed keywords

DICLOFENAC; HYALURONIC ACID; PLACEBO;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRECANCER; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; STUDENT T TEST; SUN EXPOSURE; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 33750091315     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.27749     Document Type: Article

References (12)

1. Schwartz RA. The actinic keratosis. A perspective and update. Dermatol Surg 1997;11:1009-19.
2. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988;1:795-7.
3. Dodson JM, DeSpain J, Hewett JE, Clark DP. Malignant potential of actinic keratoses and the controversy over treatment: A patient-oriented perspective. Arch Dermatol 1991;127:1029-31.
4. Marks R, Foley P, Goodman G, Hage BH, Selwood TS. Spontaneous remission of solar keratoses: The case for conservative management. Br J Dermatol 1986;115:649-55.
5. Jorizzo JL. Current and novel treatment options for actinic keratosis. J Cutan Med Surg 2004;8:13-21.
6. Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin, Y. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol 2002;146:94-100.
7. Nelson C, Rigel D, Smith S, Swanson N, Wolf J. Phase IV, openlabel assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). J Drugs Dermatol 2004;3:401-7.
8. Rivers JK. Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses. Skin Therapy Lett 2004;9:1-3.
9. Tutrone WD, Saini R, Caglar S, Weinberg JM, Crespo J. Topical therapy for actinic keratoses II: Diclofenac, colchicine and retinoids. Cutis 2003;71:373-9.
10. Jarvis B, Figgitt DP. Topical 3% diclofenac in 2.5% hyaluronic acid gel: A review of its use in patients with actinic keratoses. Am J Clin Dermatol 2003;4:203-13.
11. Wolf JE Jr, Taylor JR, Tschen E, Kang S. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001;40:709-13.
12. Rivers JK, McLean DI. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses. Arch Dermatol 1997;133:1239-42.